Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Allison Potolski

Physician Assistant Altamont, NY Physician Assistant

NPI 1730738626 CMS profile 5865693

2508 Western Ave, Altamont, NY 12009

Open in the dashboard

General payments

$6,262

267 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Allison Potolski of Altamont, NY is reported in the CMS Open Payments database as having received $6,262 across 267 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,170 57
2024 General $1,462 77
2023 General $2,685 94
2022 General $930 38
2021 General $15 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Allison Potolski
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Allison Potolski were reported at $1,170. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Allison Potolski Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $15 $132 $37–$438 $132
2022 $930 $155 $48–$522 $149
2023 $2,685 $167 $52–$557 $160
2024 $1,462 $178 $55–$600 $164
2025 $1,170 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Incyte Corporation $1,541 18 payments
  2. AbbVie, Inc. $1,112 84 payments
  3. Janssen Biotech, Inc. $643 41 payments
  4. UCB, Inc. $420 16 payments
  5. Regeneron Healthcare Solutions, Inc. $341 17 payments
  6. Genzyme Corporation $304 14 payments
  7. Sun Pharmaceutical Industries Inc. $290 13 payments
  8. Janssen Scientific Affairs, LLC $266 2 payments
  9. Lilly USA, LLC $214 11 payments
  10. Novartis Pharmaceuticals Corporation $173 8 payments
  11. Other $957 43 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $5,032 265 payments
  2. Consulting Fee $1,220 1 payment
  3. Education $10 1 payment
Products named General payments · program years 2021–2025
  1. TREMFYA $893 41 payments
  2. DUPIXENT Immunology $513 23 payments
  3. RINVOQ $474 30 payments
  4. SKYRIZI Immunology $359 34 payments
  5. Bimzelx $341 12 payments
  6. OPZELURA $321 17 payments
  7. SKYRIZI Immunology $254 18 payments
  8. TALTZ $190 10 payments
  9. ADBRY $171 8 payments
  10. DUPIXENT Inflammation And Immunology $140 8 payments
  11. Other $2,095 99 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 24 drugs

Part D claims

1,578

Median for Physician Assistant: 241

Drug cost

$553,496

Median for Physician Assistant: $4,110

Branded share of claims

7.7%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Skyrizi Pen Risankizumab-Rzaa Brand 17 $352,855
Dupixent Pen Dupilumab Brand 32 $135,012
Opzelura Ruxolitinib Phosphate Brand 13 $26,105
Tacrolimus Generic 65 $9,501
Clobetasol Propionate Generic 203 $6,908
Ketoconazole Generic 275 $5,079
Clindamycin Phosphate Generic 96 $3,905
Triamcinolone Acetonide Generic 221 $2,484
Betamethasone Dipropionate Generic 40 $2,363
Metronidazole Generic 31 $1,448

The 10 drugs with the highest cost, of 24 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 38 billing codes

Paid by Medicare

$86,632

Of which drugs: $7,951

Medicare patients

526

Average age 74

Services billed

2,944

331 women, 195 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 66%
Arthritis 42%
Ischemic heart disease 28%
Diabetes 19%
Osteoporosis 18%
Chronic kidney disease 14%
Cancer 14%
Depression 14%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) J7308 Office 16 21 $6,220
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 21 47 $28

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 21 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
RINVOQ
  • AbbVie, Inc. $290
$290 — —
SKYRIZI
  • AbbVie, Inc. $189
$189 17 —
OPZELURA
  • Incyte Corporation $171
$171 13 —
DUPIXENT
  • GENZYME CORPORATION $126
  • Regeneron Healthcare Solutions, Inc. $23
$149 32 —
Bimzelx
  • UCB, Inc. $114
$114 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 21 in the dashboard with a free account

Records

267 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record